REG - Forterra plc - Grant of Options under 2023 SAYE Scheme

ForterraAnnouncement

05/10/2023 17:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20231005:nRSE8843Oa&default-theme=true

RNS Number : 8843O  Forterra plc  05 October 2023

5 October 2023

Forterra plc

Grant of Options under 2023 SAYE Scheme

Forterra plc (the "Company") is pleased to announce that it has granted
options under its Employee Sharesave Scheme (the "Scheme") which is open to
all employees subject to certain requirements.  Participants can choose to
save up to £500 per month over a 3 year period.  Pursuant to the scheme, on
4 October 2023 the Company granted options over 5,583,774 ordinary shares of
£0.01 each.  The exercise price which was set in accordance with HM Revenue
and Customs rules was £1.32 per share.  The options have a contract start
date of 1 December 2023 and are exercisable between 1 December 2026 and 31 May
2027.  The exercise of options on maturity is not dependent upon performance
criteria.

Within the options described above, options were granted to the following
Persons Discharging Managerial Responsibilities (PDMRs)

 PDMR                                          Number of options granted
 Neil Ash (Chief Executive Officer)            14,053
 Ben Guyatt (Chief Financial Officer)          14,053
 Darren Rix (Strategy Director)                14,053
 Adam Smith (Commercial Director)              14,053
 George Stewart (Technical Projects Director)  14,053

 

Enquiries

 Forterra plc:                     +44 (0) 1604 707 600
 Ben Guyatt (CFO)
 Frances Tock (Company Secretary)

Forterra plc

Further information relating to the Company and its group can be found at
www.forterraplc.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCUVRNROUURRAA